FindTrial
Sign In

Chinese ECG and Echo Study (CHEES) in Left Ventricular Hypertrophy

Chinese ECG and Echo Study (CHEES) in Left Ventricular Hypertrophy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DOD-16007983
Enrollment
Unknown
Registered
2016-02-28
Start date
2016-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

left ventricular hypertrophy

Interventions

Gold Standard:
Index test:

Sponsors

Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 90 Years

Inclusion criteria

Inclusion criteria: Aged >=35 years, in line with one of the following conditions who can selected: 1. 12-lead ECG SV1 + RV5 or SV1 + RV6>=3.5mV; 2. Echocardiographic diagnosis of left ventricular hypertrophy (male: LVMI>=115g/m^2, female LVMI >=95g/m^2).

Exclusion criteria

Exclusion criteria: One of those who meet the following conditions can not be selected: (1) myocardial infarction, segmental wall motion abnormalities and / or left ventricular morphological abnormalities; (2) moderate or more mitral and / or aortic regurgitation; (3) left ventricular ejection fraction <45%; (4) moderate or more pericardial effusion; (5) severe arrhythmia.

Design outcomes

Primary

MeasureTime frame
LV Mass Index;Sokolow-Lyon index;—

Countries

China

Contacts

Public ContactTiangang Zhu

Peking University People's Hospital

tg_zh@aliyun.com+86 13681089526

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026